Bank Julius Baer & Co
FATE icon

Bank Julius Baer & Co’s Fate Therapeutics FATE Stock Holding History

Bank Julius Baer & Co’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-280
Closed -$1K – 532
2023
Q2 		$1K Hold
280
– – ﹤0.01% 557
2023
Q1 		$2K Hold
280
– – ﹤0.01% 581
2022
Q4 		$3K Sell
280
-9,106
-97% -$171K ﹤0.01% 566
2022
Q3 		$210K Sell
9,386
-3,742
-29% -$108K ﹤0.01% 398
2022
Q2 		$325K Sell
13,128
-6,022
-31% -$166K ﹤0.01% 370
2022
Q1 		$742K Buy
19,150
+437
+2% +$16.9K ﹤0.01% 312
2021
Q4 		$1.09M Buy
+18,713
New +$1.06M 0.01% 337

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return